Immunic to participate in investor, scientific and industry conferences in june

New york , june 2, 2025 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor, scientific and industry conferences in june: june 3-5: jefferies healthcare conference. daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking